- In May 2025, Johnson & Johnson Vision announced the launch of its next-generation multifocal contact lenses featuring enhanced light-adjusting technology designed to improve visual clarity for presbyopic patients. This innovation aims to reduce eye strain and improve comfort for daily wearers, reinforcing Johnson & Johnson’s position as a leader in vision correction solutions globally
- In April 2025, Alcon introduced an advanced intraocular lens (IOL) system equipped with extended depth-of-focus technology to improve visual outcomes after cataract surgery. The new lens received regulatory approval in key markets including the U.S. and Europe, marking a significant step forward in presbyopia management for ophthalmologists worldwide
- In March 2025, Bausch + Lomb launched a hybrid presbyopia-correcting lens designed for patients requiring both rigid gas permeable and soft lens benefits. This new product targets niche patient groups with complex vision needs, broadening the company’s portfolio and addressing unmet clinical demands.
- In February 2025, CooperVision expanded its range of progressive addition lenses (PALs) with the introduction of customizable options tailored to different occupational needs, such as digital device use and outdoor activities. This move reflects the growing trend towards personalized vision care solutions and enhances CooperVision’s competitive edge
- In January 2025, Carl Zeiss Meditec announced a strategic partnership with leading ophthalmology clinics across Asia-Pacific to accelerate adoption of its cutting-edge corneal inlay technology. This collaboration focuses on clinical training and research, aiming to improve treatment outcomes and raise awareness of presbyopia-correcting devices in emerging markets
